Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity
- PMID: 20798982
- PMCID: PMC2981638
- DOI: 10.1007/s10897-010-9316-y
Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity
Abstract
This study explored awareness of risk factors for hereditary breast and ovarian cancer (HBOC), awareness, knowledge and concerns about genetic testing, and preference for how to have genetic testing recommended by a care provider among at-risk Hispanic women. Differences in these factors among Mexican, Cuban, and Puerto Rican women were also examined. Women with a personal or family history of breast or ovarian cancer from the Tampa Bay Area participated in a qualitative interview (N = 53). Data were analyzed using a combination of open and axial coding with a grounded theory approach. Study participants in all groups reported: being aware that family history was a breast cancer risk factor, limited knowledge of genetic testing, fear of test results, concerns about children's risks, and no physician referral for genetic testing. Noteworthy sub-ethnic differences included preferences for physician recommendation and information about genetic testing. This study provides important preliminary information about areas related to HBOC that require additional education in the Hispanic community as a whole and by sub-ethnicity.
Similar articles
-
Preferences for hereditary breast and ovarian cancer information among Mexican, Cuban and Puerto Rican women at risk.Public Health Genomics. 2011;14(4-5):248-58. doi: 10.1159/000284582. Epub 2010 Feb 12. Public Health Genomics. 2011. PMID: 20150724 Free PMC article.
-
A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer.Genet Test Mol Biomarkers. 2010 Feb;14(1):99-106. doi: 10.1089/gtmb.2009.0088. Genet Test Mol Biomarkers. 2010. PMID: 19929403 Free PMC article.
-
Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act.Genet Test Mol Biomarkers. 2019 Feb;23(2):75-83. doi: 10.1089/gtmb.2018.0253. Epub 2019 Jan 24. Genet Test Mol Biomarkers. 2019. PMID: 30676117 Free PMC article.
-
Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.Rev Recent Clin Trials. 2014;9(4):245-53. doi: 10.2174/1574887110666150127110314. Rev Recent Clin Trials. 2014. PMID: 25626062 Free PMC article. Review.
-
Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.J Racial Ethn Health Disparities. 2019 Jun;6(3):570-583. doi: 10.1007/s40615-018-00556-7. Epub 2019 Apr 8. J Racial Ethn Health Disparities. 2019. PMID: 30963508 Review.
Cited by
-
Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.JAMA Dermatol. 2018 Jun 1;154(6):684-693. doi: 10.1001/jamadermatol.2018.0592. JAMA Dermatol. 2018. PMID: 29801061 Free PMC article. Clinical Trial.
-
Beliefs and willingness towards participating in genetic testing for depression in low-income and racial/ethnic minority mothers at-risk.Arch Psychiatr Nurs. 2022 Dec;41:153-165. doi: 10.1016/j.apnu.2022.07.002. Epub 2022 Jul 18. Arch Psychiatr Nurs. 2022. PMID: 36428043 Free PMC article.
-
A qualitative study of Latinx parents' experiences of clinical exome sequencing.J Genet Couns. 2020 Aug;29(4):574-586. doi: 10.1002/jgc4.1276. Epub 2020 Apr 16. J Genet Couns. 2020. PMID: 32298033 Free PMC article.
-
Challenges in recruiting Mexican women for cancer genetics research.J Community Genet. 2011 Mar;2(1):43-7. doi: 10.1007/s12687-010-0032-y. Epub 2010 Dec 1. J Community Genet. 2011. PMID: 22109723 Free PMC article.
-
Provider's Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer.Healthcare (Basel). 2018 Sep 17;6(3):116. doi: 10.3390/healthcare6030116. Healthcare (Basel). 2018. PMID: 30227649 Free PMC article.
References
-
- AMA Identifying and Managing Hereditary Risk for Breast and Ovarian Cancer: Case Studies in Genetic Testing. An AMA Continuing Medical Education Program. 2002a.
-
- Bosompra K, Ashikaga T, Flynn BS, Worden JK, Solomon LJ. Psychosocial factors associated with the public’s willingness to pay for genetic testing for cancer risk: a structural equations model. Health Education Research. 2001;16(2):157–172. - PubMed
-
- Browner CH, Preloran HM, Casado MC, Bass H, Walker A. Genetic counseling gone awry: some consequences of miscommunication between prenatal genetic service providers and Latina clients. Social Science and Medicine. 2003;56(9):1933–1946. - PubMed
-
- Carter RF. BRCA1, BRCA2 and breast cancer: a concise clinical review. Clinical and Investigative Medicine. 2001;24(3):147–157. - PubMed
-
- Chavez LR, Hubbell FA, McMullin JM, Martinez RG, Mishra SI. Understanding knowledge and attitudes about breast cancer. A cultural analysis. Archives of Family Medicine. 1995;4(2):145–152. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical